| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |